Laurus Labs CEO Satyanarayana Chava on CDMO growth, peptides and margins
Chava talks through capacity investment as the CDMO business grows, with peptides part of the plan and margins near 30% in focus.
Recap by typeshit. Post by Wegro App on X.
Chava talks through capacity investment as the CDMO business grows, with peptides part of the plan and margins near 30% in focus.
Recap by typeshit. Post by Wegro App on X.
A Weird Science riff frames her before and after, crediting GLP-1 medication for taking her from 233 pounds down to 133.
The Post digs into how weight loss on GLP-1 drugs may be affecting marriages, and finds the answer is not simple.
She explains that GLP-1 drugs copy a hormone the body already makes, and says they can curb appetite, slow digestion and help with blood sugar.
She landed the Daily Mail front page this week discussing Ozempic face and the steps she says she took to protect her own.
Injectable peptides lead a daily AP health briefing, alongside changes to infant formula and advice on keeping kids safe from lead.
The doctor walks through what can happen when people come off weight loss injections, a growing question as more users consider quitting.
Loading…